Filing Details

Accession Number:
0001214659-21-006636
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-16 17:21:10
Reporting Period:
2021-06-14
Accepted Time:
2021-06-16 17:21:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1581280 Twist Bioscience Corp TWST Biological Products, (No Disgnostic Substances) (2836) 462058888
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1753672 Paula Green C/O Twist Bioscience Corporation
681 Gateway Blvd.
South San Francisco CA 94080
Svp Of Human Resources No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-06-14 300 $113.48 20,095 No 4 S Direct
Common Stock Acquisiton 2021-06-14 6,798 $5.95 26,893 No 4 M Direct
Common Stock Acquisiton 2021-06-14 2,352 $8.82 29,245 No 4 M Direct
Common Stock Acquisiton 2021-06-14 1,663 $23.33 30,908 No 4 M Direct
Common Stock Acquisiton 2021-06-14 3,048 $26.66 33,956 No 4 M Direct
Common Stock Disposition 2021-06-14 10,921 $113.34 23,035 No 4 S Direct
Common Stock Disposition 2021-06-14 500 $114.96 22,535 No 4 S Direct
Common Stock Disposition 2021-06-14 2,440 $115.90 20,095 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2021-06-14 6,798 $0.00 6,798 $5.95
Common Stock Employee Stock Option (right to buy) Disposition 2021-06-14 2,352 $0.00 2,352 $8.82
Common Stock Employee Stock Option (right to buy) Disposition 2021-06-14 1,663 $0.00 1,663 $23.33
Common Stock Employee Stock Option (right to buy) Disposition 2021-06-14 3,048 $0.00 3,048 $26.66
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
11,045 2026-03-21 No 4 M Direct
1,046 2027-09-28 No 4 M Direct
26,137 2029-10-23 No 4 M Direct
31,956 2028-11-18 No 4 M Direct
Footnotes
  1. Represents the weighted average sales price per share. The shares sold at prices ranging from $113.09 to $113.88 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
  2. Represents the weighted average sales price per share. The shares sold at prices ranging from $113.00 to $113.81 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
  3. Represents the weighted average sales price per share. The shares sold at prices ranging from $114.53 to $115.08 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
  4. Represents the weighted average sales price per share. The shares sold at prices ranging from $115.58 to $116.18 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
  5. The option is immediately exercisable. 25% of the shares subject to the option vested on September 1, 2016 and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
  6. The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
  7. 25% of the shares subject to the option vested and became exercisable on October 24, 2020, and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
  8. 20% of the shares subject to the option vested and became exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.